(Q80503566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

chronic idiopathic myelofibrosis

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

L Pasqualucci

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

S Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

G Meloni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

S Schnittger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

S Gattenlohner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

A Liso

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M Di Ianni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M P Martelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

E Pescarmona

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

R Foa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

T Haferlach

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

R C Skoda

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

17 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1459-1463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200037%20AND%20SRC:MED&resulttype=core&format=json

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

Detecting the JAK2 V617F mutation in fresh and 'historic' blood and bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021

Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405093

7 January 2021